Clinical Outcomes of Anti-Androgen Withdrawal and Subsequent Alternative Anti-Androgen Therapy for Advanced Prostate Cancer Following Failure of Initial Maximum Androgen Blockade

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2016.817
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Androgen Deprivation Therapy for Prostate Cancer

2017English

Prognostic Factors for Estrogen Therapy of Relapsed Prostate Cancer After Maximal Androgen Blockade (Mab)

Japanese Journal of Urology
Urology
2010English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

Combined Androgen Blockade in Localized Prostate Cancer Treated With Definitive Radiation Therapy

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2019English

Comparative Clinical Effects and Cost–effectiveness of Maximum Androgen Blockade, Docetaxel With Androgen Deprivation Therapy and ADT Alone for the Treatment of mHSPC in China

Journal of Comparative Effectiveness Research
Health Policy
2019English

A Study of Correlationship Between Therapeutic Efficacy of Anti-Androgen Therapy in Prostatic Cancer and Androgen Receptor Content of Prostatic Cancer Tissue

Japanese Journal of Urology
Urology
1984English

Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer

Journal of Oncology Practice
Health PolicyOncology
2018English

Current Status and Prospects of Androgen Depletion Therapy for Prostate Cancer

Best Practice and Research in Clinical Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy